Research Paper Volume 10, Issue 9 pp 2356—2366
A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer
Figure 2. The association between seven-lncRNA signature and overall survival in discovery and two validation groups. Kaplan-Meier survival curves were plotted to estimate the overall survival probabilities for the low- versus high-risk group in the discovery group (A), validation group-1 (B) and validation group-2 (C). (D) Meta-analysis was performed using the prognostic results of three groups.